Down-regulation of BRCA1 and BRCA2 in human ovarian cancer cells exposed to adriamycin and ultraviolet radiation

International Journal of Cancer

Volumn 77, Issue 4, 1998, Pages 600-609

  Fan, Saijun ^a   Twu, Nae Fang ^b   Wang, Ji An ^a   Yuan, Ren Qi ^a   Andres, Janet ^a   Goldberg, Itzhak D ^a   Rosen, Eliot M ^a  

^a LONG ISLAND JEWISH MEDICAL CENTER   (United States)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CAMPTOTHECIN; CHLORMETHINE; DOXORUBICIN; ETOPOSIDE; PACLITAXEL; VINCRISTINE;

ARTICLE; CANCER CHEMOTHERAPY; CANCER INHIBITION; CANCER RADIOTHERAPY; CELL CYCLE; CELL SURVIVAL; CELL VIABILITY; CYTOTOXICITY; DNA DAMAGE; DNA SEQUENCE; DOSE TIME EFFECT RELATION; GENE EXPRESSION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; ONCOGENE; OVARY CANCER; PRIORITY JOURNAL; ULTRAVIOLET IRRADIATION;

EID: 0031872850     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980812)77:4<600::AID-IJC21>3.0.CO;2-8     Document Type: Article

References (22)

1. ANDRES, J.L., FAN, S., TURKEL, G.J., WANG, J.-A., TWU, N.-F., YUAN, R.-Q., LAMSZUS, K., GOLDBERG, I.D. and ROSEN, E.M., Regulation of BRCA1 and BRCA2 expression in human breast cancer cells by DNA-camaging agents. Oncogene (1998) (In press).
2. DEBERNARDIS, D., SIRE, E.G., DE FEUDIS, P., VIKHANSKAYA, F., VIKHANSKAYA, F., VALENTI, M., RUSSO, P., PARODI, S., D'INCALCI, M. and BROGGINI, M., p53 status does not affect sensitivity of human ovarian cancer cell lines to paclitaxel. Cancer Res., 57, 870-874 (1997).
3. EASTON, D.F., FORD, D. and BISHOP, D.T., Breast and ovarian cancer incidence in BRCA1-mutation carriers. The Breast Cancer Linkage Consortium. Amer. J. Hum. Genet., 56, 265-271 (1995).
4. FAN, S., EL-DEIRY, W.S., BAE, I., FREEMAN, J., JONDLE, D., BHATIA, K., FORNACE, A.J., JR., MAGRATH, I., KOHN, K.W. and O'CONNOR, P.M., p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents. Cancer Res., 54, 5824-5830 (1994).
5. FUTREAL, P.A. and 26 OTHERS, BRCA1 mutations in primary breast and ovarian carcinomas. Science, 266, 120-122 (1994).
6. GAYTHER, S.A. and 15 OTHERS, Germline mutations of the BRCA1 gene in breast, ovarian cancer families: evidence for a genotype/phenotype correlation. Nature (Genet.), 11, 428-133 (1995).
7. GUDAS, J.M., NGUYEN, H., LI, T. and COWAN, K.H., Hormone dependent regulation of BRCA1 in human breast cancer cells. Cancer Res., 55, 4561-4565 (1995).
8. HAKEM, R. and 14 OTHERS, The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse. Cell, 85, 1009-1023 (1996).
9. HOLT, J.T., THOMPSON, M.E., SZABO, C., ROBINSON-BENION, C., ARTEAGA, C.L., KING, M.-C. and JENSEN, R.A., Growth retardation and tumor inhibition by BRCA1. Nature (Genet.), 12, 298-302 (1996).
10. KOONIN, V.F., ALTSCHUL, S.F. and BORK, P., BRCA1 protein products: functional motifs. Nature (Genet.), 13, 266-267 (1996).
11. LARSON, J.S., TONKINSON, J.L. and LAI, M.T., A BRCA1 mutant alters G2-M cell cycle control in human mammary epithelial cells. Cancer Res., 57, 3351-3355 (1997).
12. MIKI, Y. and 44 OTHERS, A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science, 266, 66-71 (1994).
13. O'CONNOR, P.M. and 12 OTHERS, Characterization of the p53 tumor suppressor pathway in cell lines of the National Cancer Institute anticancer drug screen and correlations with the growth-inhibitory potency of 123 anticancer agents. Cancer Res., 57, 4285-4309 (1997).
14. RAJAN, J.V., WANG, M., MARQUIS, S.T. and Chodosh, L.A., Brca2 is coordinately regulated with Brca1 during proliferation and differentiation in mammalian epithelial cells. Proc. Nat. Acad. Sci. (Wash.), 93, 3078-3083, (1996).
15. SCULLY, R., CHEN, J., OCHS, R.L., KEEGAN, K., HOEKSTRA, M., FEUNTEUN, J. and LIVINGSTON, D.M., Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage. Cell, 90, 425-435 (1997a).
16. SCULLY, R., CHEN, J., PLUG, A., XIAO, P., WEAVER, D., FEUNTEAU, J., ASHLEY, T. and LIVINGSTON, D., Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell, 88, 265-275 (1997b).
17. SHAO, N., CHAI, Y.L., SHYAM, E., REDDY, P. and RAO, V.M., Induction of apoptosis by tumor suppressor protein BRCA1. Oncogene, 13, 1-7 (1996).
18. SHARAN, S.K., MORIMATSU, M., ALBRECHT, U., LIM, D.-S., REGEL. E., DINH, C., SANDS, A., EICHELE, G., HASTY, P. and BRADLEY, A., Embryo lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2. Nature (Lond.), 386, 804-810 (1997).
19. WAF1/CIP1. Nature (Lond.), 389, 187-190 (1997).
20. STRUEWING, J.P., HARTGE, P., WACHOLDER, S., BAKER, S.M., BERLIN, M., MCADAM, S.M., TIMMERMAN, M.M., BRODY, L.C. and TUCKER, M.A., The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N. Engl. J. Med., 336, 1401-1408 (1997).
21. TAVTIGIAN, S.V. and 50 OTHERS, The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat. Genet, 12: 333-337 (1996).
22. TIRKKONEN, M., JOHANNSON, O., AGNARSSON, B.A., OLSSON, H., INGVARSSON, S., KARHU, R., TANNER, M., ISOLA, J., BARKARDOTTIR, R.B., BORG, A. KALLIONIEMI, O.P., Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations. Cancer Res., 57, 1222-1227 (1997).